ID: ALA5170093

Max Phase: Preclinical

Molecular Formula: C19H18O3

Molecular Weight: 294.35

Associated Items:

Representations

Canonical SMILES:  O=C(O)/C=C1\CCCc2cc(-c3ccccc3)ccc2C1O

Standard InChI:  InChI=1S/C19H18O3/c20-18(21)12-16-8-4-7-15-11-14(9-10-17(15)19(16)22)13-5-2-1-3-6-13/h1-3,5-6,9-12,19,22H,4,7-8H2,(H,20,21)/b16-12+

Standard InChI Key:  NUTNFGZHQLFKOZ-FOWTUZBSSA-N

Associated Targets(Human)

CaM kinase II alpha 1938 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

CaM kinase II alpha 109 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 294.35Molecular Weight (Monoisotopic): 294.1256AlogP: 3.73#Rotatable Bonds: 2
Polar Surface Area: 57.53Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.46CX Basic pKa: CX LogP: 3.81CX LogD: 0.96
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.66Np Likeness Score: 0.43

References

1. Tian Y, Shehata MA, Gauger SJ, Veronesi C, Hamborg L, Thiesen L, Bruus-Jensen J, Royssen JS, Leurs U, Larsen ASG, Krall J, Solbak SMØ, Wellendorph P, Frølund B..  (2022)  Exploring the NCS-382 Scaffold for CaMKIIα Modulation: Synthesis, Biochemical Pharmacology, and Biophysical Characterization of Ph-HTBA as a Novel High-Affinity Brain-Penetrant Stabilizer of the CaMKIIα Hub Domain.,  65  (22.0): [PMID:36346645] [10.1021/acs.jmedchem.2c00805]

Source